Literature DB >> 19114522

Oxidation of lanthionines renders the lantibiotic nisin inactive.

Shawanda Wilson-Stanford1, Anastasia Kalli, Kristina Håkansson, James Kastrantas, Ravi S Orugunty, Leif Smith.   

Abstract

The peptide antibiotic nisin A belongs to the group of antibiotics called lantibiotics. They are classified as lantibiotics because they contain the structural group lanthionine. Lanthionines are composed of a single sulfur atom that is linked to the beta-carbons of two alanine moieties. These sulfur atoms are vulnerable to environmental oxidation. A mild oxidation reaction was performed on nisin A to determine the relative effects it would have on bioactivity. High-mass-accuracy Fourier transform ion cyclotron resonance mass spectrometry data revealed the addition of seven, eight, and nine oxygens. These additions correspond to the five lanthionines, two methionines, and two histidines that would be susceptible to oxidation. Subsequent bioassays revealed that the oxidized form of nisin A had a complete loss of bactericidal activity. In a competition study, the oxidized nisin did not appear to have an antagonistic affect on the bioactivity of nisin A, since the addition of an equal molar concentration of the oxidized variant did not have an influence on the bactericidal activity of the native antibiotic. Electron microscopy data revealed that the oxidized forms were still capable of assembling into large circular complexes, demonstrating that oxidation does not disrupt the lateral assembly mechanism of the antibiotic. Affinity thin-layer chromatography and fluorescence microscopy experiments suggested that the loss of activity is due to the inability of the oxidized form of nisin to bind to the cell wall precursor lipid II. Given the loss of bioactivity following oxidation, oxidation should be an important factor to consider in future production, purification, pharmacokinetic, and pharmacodynamic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114522      PMCID: PMC2648158          DOI: 10.1128/AEM.01864-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  30 in total

1.  Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics.

Authors:  A Gravesen; K Sørensen; F M Aarestrup; S Knøchel
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

2.  Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell.

Authors:  Richard A Daniel; Jeff Errington
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.

Authors:  Shang-Te D Hsu; Eefjan Breukink; Eugene Tischenko; Mandy A G Lutters; Ben de Kruijff; Robert Kaptein; Alexandre M J J Bonvin; Nico A J van Nuland
Journal:  Nat Struct Mol Biol       Date:  2004-09-12       Impact factor: 15.369

4.  pbp2229-mediated nisin resistance mechanism in Listeria monocytogenes confers cross-protection to class IIa bacteriocins and affects virulence gene expression.

Authors:  Anne Gravesen; Birgitte Kallipolitis; Kim Holmstrøm; Poul Erik Høiby; Manilduth Ramnath; Susanne Knøchel
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

5.  Gallidermin: a new lanthionine-containing polypeptide antibiotic.

Authors:  R Kellner; G Jung; T Hörner; H Zähner; N Schnell; K D Entian; F Götz
Journal:  Eur J Biochem       Date:  1988-10-15

6.  Function of Lactococcus lactis nisin immunity genes nisI and nisFEG after coordinated expression in the surrogate host Bacillus subtilis.

Authors:  Torsten Stein; Stefan Heinzmann; Irina Solovieva; Karl-Dieter Entian
Journal:  J Biol Chem       Date:  2002-10-11       Impact factor: 5.157

7.  Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

Authors:  E Breukink; I Wiedemann; C van Kraaij; O P Kuipers; H G Sahl; B de Kruijff
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

8.  Resistance of Gram-positive bacteria to nisin is not determined by lipid II levels.

Authors:  Naomi E Kramer; Eddy J Smid; Jan Kok; Ben de Kruijff; Oscar P Kuipers; Eefjan Breukink
Journal:  FEMS Microbiol Lett       Date:  2004-10-01       Impact factor: 2.742

9.  Fast induction of nisin resistance in Streptococcus thermophilus INIA 463 during growth in milk.

Authors:  Sonia Garde; Marta Avila; Margarita Medina; Manuel Nuñez
Journal:  Int J Food Microbiol       Date:  2004-11-01       Impact factor: 5.277

10.  Elucidation of the antimicrobial mechanism of mutacin 1140.

Authors:  Leif Smith; Hester Hasper; Eefjan Breukink; Jan Novak; Jirí Cerkasov; J D Hillman; Shawanda Wilson-Stanford; Ravi S Orugunty
Journal:  Biochemistry       Date:  2008-02-12       Impact factor: 3.162

View more
  14 in total

1.  Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.

Authors:  Jerome Escano; Akshaya Ravichandran; Bita Salamat; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

2.  Interaction with lipid II induces conformational changes in bovicin HC5 structure.

Authors:  Aline Dias Paiva; Nicole Irving; Eefjan Breukink; Hilário Cuquetto Mantovani
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

3.  Insights into the functionality of the putative residues involved in enterocin AS-48 maturation.

Authors:  Rubén Cebrián; Mercedes Maqueda; José Luis Neira; Eva Valdivia; Manuel Martínez-Bueno; Manuel Montalbán-López
Journal:  Appl Environ Microbiol       Date:  2010-09-10       Impact factor: 4.792

4.  Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.

Authors:  Mengxin Geng; Frank Austin; Ronald Shin; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

5.  Synthesis and activity of thioether-containing analogues of the complement inhibitor compstatin.

Authors:  Patrick J Knerr; Apostolia Tzekou; Daniel Ricklin; Hongchang Qu; Hui Chen; Wilfred A van der Donk; John D Lambris
Journal:  ACS Chem Biol       Date:  2011-05-23       Impact factor: 5.100

6.  Site-directed mutations in the lanthipeptide mutacin 1140.

Authors:  Shaorong Chen; Shawanda Wilson-Stanford; William Cromwell; Jeffrey D Hillman; Adam Guerrero; Charlotte A Allen; Joseph A Sorg; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

7.  Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering.

Authors:  Guangshun Wang
Journal:  Curr Biotechnol       Date:  2012-02

8.  Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.

Authors:  Mengxin Geng; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2018-07-17       Impact factor: 4.792

9.  Pectin-gellan films intended for active food packaging: release kinetics of nisin and physico-mechanical characterization.

Authors:  Lorena Rivera-Hernández; Norberto Chavarría-Hernández; Ma Del Rocío López Cuellar; Víctor Manuel Martínez-Juárez; Adriana-Inés Rodríguez-Hernández
Journal:  J Food Sci Technol       Date:  2020-09-21       Impact factor: 3.117

10.  Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.

Authors:  Evelyn M Molloy; Des Field; Paula M O' Connor; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.